Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Common Equity (2016 - 2026)

Rockwell Medical filings provide 16 years of Common Equity readings, the most recent being $37.0 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 13.55% to $37.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.0 million, a 13.55% increase, with the full-year FY2025 number at $37.0 million, up 13.55% from a year prior.
  • Common Equity hit $37.0 million in Q4 2025 for Rockwell Medical, roughly flat from $37.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $37.0 million in Q3 2025 to a low of -$4.8 million in Q1 2022.
  • Median Common Equity over the past 5 years was $21.0 million (2023), compared with a mean of $20.5 million.
  • The widest YoY moves for Common Equity: up 456.45% in 2022, down 118.36% in 2022.
  • Rockwell Medical's Common Equity stood at $2.5 million in 2021, then skyrocketed by 456.45% to $14.1 million in 2022, then skyrocketed by 50.94% to $21.3 million in 2023, then soared by 53.05% to $32.6 million in 2024, then grew by 13.55% to $37.0 million in 2025.
  • The last three reported values for Common Equity were $37.0 million (Q4 2025), $37.0 million (Q3 2025), and $30.4 million (Q2 2025) per Business Quant data.